article thumbnail

Teledyne Cuts Outlook On Sales Slowdown In Energy Markets

socalTECH

Thousand Oaks-based Teledyne Technologies said this morning that it is cutting its outlook for the third quarter and full year, due to decline in sales in energy-related products. Teledyne is a diversified provider of aerospace, energy, defense, electronics, imaging, engineered systems, and other products.

Sales 100
article thumbnail

Interview with Brett Crosby and Brew Johnson, PeerStreet

socalTECH

I grew up in Thousand Oaks, went to USC, and we met each other way back in the 90's. The easiest way to look at it, from the tech perspective, is that we are very similar to LendingClub. We said, let's create a technology marketplace and platform that creates benefits for those existing lenders, as well as investors.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Makers Making The Sci-Fi Tricorder A Reality With VOXearch

socalTECH

They wanted to do 3-D X-rays, but at the time, there was not technology available to do that. Unfortunately, UCLA''s money dried up due to legal issues. The concept of the incubator is we''re raising a fund here locally and ten percent is local the other 90 percent on AngelList, and we''ll be locating here in the town of Thousand Oaks.

Startup 262
article thumbnail

Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More

Xconomy

—Drug price news: While drug-purchasing agent CVS Health said it would bar several high-priced products from its menu of choices, including the leading prostate cancer treatment enzalutamide (Xtandi), it emerged that GSK is pricing gene therapy Strimvelis at $665,000 for a single dose, as STAT reports. . SMA has no approved treatments.

News 40